Solvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (‘CNS’) disorders,…
Investing
Romios CEO Letter to Shareholders Recaps Progress and Presents Case for Share Rollback in Support of Financing the First-Ever Drilling of the Trek South Porphyry Copper-Gold Prospect, in 2026
Romios Gold Resources Inc. (TSXV: RG,OTC:RMIOF) (OTCID: RMIOF) (FSE: D4R) (‘Romios Gold’ or the ‘Company’). In advance of the…